Respiratory Disease Testing/Diagnostics Market Analysis By Product (Imaging Tests, Respirometers, Blood Gas Tests), By End-use (Hospitals, Physicians Clinic, Clinical Laboratories, Ambulatory Services), And Segment Forecasts, 2014 - 2025

Published: Apr, 2017 | Pages: 90 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)

The global respiratory diseases testing market is expected to reach USD 6.7 billion by 2025, according to a new report by Grand View Research, Inc. The market is driven by the rising prevalence of respiratory diseases. As per Forum of International Respiratory Societies, more than 200 million people across the globe suffered from Chronic Obstructive Pulmonary Disease (COPD) and 235 million suffered from asthma in 2014. In addition, the source stated that more than 50 million people struggle with occupational lung diseases annually. Thus, constantly growing target patient population is anticipated to drive the growth.

The adoption of innovative technologies, such as Computed Tomography (CT), for COPD diagnosis is expected to drive the growth. The other new technology in acute medical management of COPD is pulse oximeter that is used for outpatient monitoring. Airway management plays a main role in testing and management of COPD. Also, with recent technological innovations, there has been a 12.1 % increase in the use of Noninvasive Mechanical Ventilation (NIV) for management of COPD. Along with technological advancements, use of digital radiography (X-ray) and advanced portable spirometers is gaining momentum in the market.

Further key findings from the study suggest:

The growing prevalence of COPD and asthma across the globe is expected to increase the demand for respiratory disease testing devices and thereby drive the market growth

In products, imaging tests held the largest share in 2016 due to rapid development and adoption of innovative technologies

In respiratory measurement, spirometers, pulse oximeters, ventilators, capnographs, and other noninvasive ventilators used for measurement of lung capacity are expected to grow at a rate of more than 4% over the forecast period

In end-use, hospitals segment held the largest share in 2016 and is anticipated to grow over the forecast period

North America the largest market share in 2016. Growing prevalence of respiratory diseases such as COPD, asthma is increasing the demand for respiratory disease testing/diagnostic in North American countries.

Asia Pacific region is expected to grow at the fastest rate during the forecast period. This growth can be attributed to various factors such as improving health care infrastructure and increasing patient awareness regarding the availability of new diagnostic techniques for respiratory diseases, such as COPD & asthma.

Some of the major players competing in this market include, but are not limited to, Becton Dickinson (Carefusion Corporation); Koninklijke Philips N.V. (Respironics); ResMed Company; Fischer & Paykel; and Medtronic. These players are strong brands in the market as they have elaborate product portfolios in respiratory disease testing market.

 Table of Contents

Chapter 1 Research Methodology
                1.1 Information Procurement
                1.2 Data Analysis
                1.3 Approaches for Market Estimation
                    1.3.1 Approach 1: Demand analysis& bottom-up approach
                    1.3.2 Approach 2: Top-down market estimation
                    1.3.3 Approach 3: Commodity flow and bottom-up market estimation
                    1.3.4 Approach 4: KoL perspective-based market sizing
Chapter 2 Executive Summary
                2.1 Market Snapshot
Chapter 3 Respiratory Disease Testing Market Variables, Trends & Scope
                3.1 Market Segmentation& Scope
                    3.1.1 Market driver analysis
                        3.1.1.1 Increasing prevalence of respiratory diseases
                        3.1.1.1 Technological advancement in respiratory disease testing
                    3.1.2 Market restraint analysis
                        3.1.3.1 Low adoption rate of digital radiography system and advanced spirometer
                        3.1.3.2 High cost associated with COPD diagnosis and testing
                3.2 Penetration & Growth Prospect Mapping
                3.3 Respiratory Disease Testing Market- PESTLE Analysis
                3.4 Industry Analysis-Porter's
Chapter 4 Respiratory Disease Testing: Product Estimates & Trend Analysis
                4.1 Respiratory Disease Testing Market: Product Movement Analysis
                4.2 Imaging Tests
                    4.2.1 Market estimates & segment forecast, 2014 - 2025 (USD million)
                4.3 Respiratory Measurement Devices
                    4.3.1 Market estimates, 2014 - 2025 (USD Million)
                    4.3.2 Pulse oximetry systems
                        4.3.2.1 Market estimates & segment forecast, 2014 - 2025 (USD Million)
                    4.3.4 Capnographs
                        4.3.4.1 Market estimates & segment forecast, 2014 - 2025 (USD Million)
                    4.3.5 Spirometers
                        4.3.5.1 Market estimate & segment forecast, 2014 - 2025 (USD Million)
                    4.3.6 Peak Flowmeters
                        4.3.6.1 Market estimate & segment forecast, 2014 - 2025 (USD Million)
                4.4 Blood Gas Tests
                    4.4.1 Market estimate & segment forecast, 2014 - 2025 (USD Million)
                4.5 Others
                    4.5.1 Market estimates & segment forecast, 2014 - 2025 (USD Million)
Chapter 5 Respiratory Disease Testing: End-use Estimates & Trend Analysis
                5.1 Respiratory Disease Testing Market: End-use Movement Analysis
                5.2 Hospitals
                    5.2.1 Market estimates & segment forecast, 2014 - 2025 (USD Million)
                5.3 Physician Clinics
                    5.3.1 Market estimates & segment forecast, 2014 - 2025 (USD Million)
                5.4 Clinical Laboratories
                    5.4.1 Market estimates & segment forecast, 2014 - 2025 (USD Million)
                5.5 Others
                    5.5.1 Market estimates & segment forecast, 2014 - 2025 (USD Million)
Chapter 6 Respiratory Disease Testing: Regional Estimates & Trend Analysis, by Product & End-use
                6.1 Respiratory Disease Testing Market Share By Region, 2016 & 2025
                6.2 North America
                    6.2.1 North America respiratory disease testing market, by product, 2014 - 2025 (USD Million)
                    6.2.2 North America respiratory disease testing market, by end-use, 2014 - 2025 (USD Million)
                    6.2.3 U.S.
                        6.2.3.1 U.S. respiratory disease testing market, by product, 2014 - 2025 (USD Million)
                        6.2.3.2 U.S. respiratory disease testing market, by end-use, 2014 - 2025 (USD Million)
                    6.2.4 Canada
                        6.2.4.1 Canada respiratory disease testing market, by product, 2014 - 2025 (USD Million)
                        6.2.4.2 Canada respiratory disease testing market, by end-use, 2014 - 2025 (USD Million)
                6.3 Europe
                    6.3.1 Europe respiratory disease testing market, by product, 2014 - 2025 (USD Million)
                    6.3.2 Europe respiratory disease testing market, by end-use, 2014 - 2025 (USD Million)
                    6.3.3 UK
                        6.3.3.1 UK respiratory disease testing market ,by product, 2014 - 2025 (USD Million)
                        6.3.3.2 UK respiratory disease testing market, by end-use, 2014 - 2025 (USD Million)
                    6.3.4 Germany
                        6.3.4.1 Germany respiratory disease testing market, by product, 2014 - 2025 (USD Million)
                        6.3.4.2 Germany respiratory disease testing market, by end-use, 2014 - 2025 (USD Million)
                6.4 Asia Pacific
                    6.4.1 Asia Pacific respiratory disease testing market, by product, 2014 - 2025 (USD Million)
                    6.4.2 Asia Pacific respiratory disease testing market, by end-use, 2014 - 2025 (USD Million)
                    6.4.3 Japan
                        6.4.3.1 Japan respiratory disease testing market, by product, 2014 - 2025 (USD Million)
                        6.4.3.2 Japan respiratory disease testing market, by end-use, 2014 - 2025 (USD Million)
                    6.4.4 China
                        6.4.4.1 China respiratory disease testing market, by product, 2014 - 2025 (USD Million)
                        6.4.4.2 China respiratory disease testing market, by end-use, 2014 - 2025 (USD Million)
                6.5 Latin America
                    6.5.1 Latin America respiratory disease testing market, by product, 2014 - 2025 (USD Million)
                    6.5.2 Latin America respiratory disease testing market, by end-use, 2014 - 2025 (USD Million)
                    6.5.3 Brazil
                        6.5.3.1 Brazil respiratory disease testing market, by product, 2014 - 2025 (USD Million)
                        6.5.3.2 Brazil respiratory disease testing market, by end-use, 2014 - 2025 (USD Million)
                    6.5.4 Mexico
                        6.5.4.1 Mexico respiratory disease testing market, by product, 2014 - 2025 (USD Million)
                        6.5.2.2 Mexico respiratory disease testing market, by end-use, 2014 - 2025 (USD Million)
                6.6 MEA
                    6.6.1 MEA respiratory disease testing market, by product, 2014 - 2025 (USD Million)
                    6.6.2 MEA respiratory disease testing market, by end-use, 2014 - 2025 (USD Million)
                    6.6.3 South Africa
                        6.6.3.1 South Africa respiratory disease testing market, by product, 2014 - 2025 (USD Million)
                        6.6.3.2 South Africa respiratory disease testing market, by end-use, 2014 - 2025 (USD Million)
Chapter 7 Competitive Landscape
                7.1 Strategy framework
                7.2 Participant categorization
                7.3 Company Profiles
                    7.3.1 Becton Dickinson & Company
                        7.3.1.1 Company overview
                        7.3.1.2 Financial Performance
                        7.3.1.3 Geographic foothold
                        7.3.1.4 Product benchmarking
                        7.3.1.5 Strategic initiatives
                    7.3.2 Koninklijke Philips N.V.
                        7.3.2.1 Company overview
                        7.3.2.2 Financial Performance
                        7.3.2.3 Geographic foothold
                        7.3.2.4 Product benchmarking
                        7.3.2.5 Strategic Initiatives
                    7.3.3 ResMed
                        7.3.3.1 Company overview
                        7.3.3.2 Financial Performance
                        7.3.3.3 Geographic foothold
                        7.3.3.4 Product benchmarking
                        7.3.3.5 Strategic initiatives
                    7.3.4 Fischer & Paykel
                        7.3.4.1 Company overview
                        7.3.4.2 Financial Performance
                        7.3.4.3 Geographic foothold
                        7.3.4.4 Product benchmarking
                        7.3.4.5 Strategic initiatives
                    7.3.5 Medtronic
                        7.3.5.1 Company overview
                        7.3.5.2 Financial Performance
                        7.3.5.3 Geographic foothold
                        7.3.5.4 Product benchmarking
                        7.3.5.5 Strategic initiatives
                    7.3.6 MGC Diagnostics Corporation and Subsidiaries
                        7.3.6.1 Company overview
                        7.3.6.2 Financial Performance
                        7.3.6.3 Geographic foothold
                        7.3.6.4 Product benchmarking
                        7.3.6.5 Strategic initiatives
                    7.3.7 CAREstream Medical, Ltd.
                        7.3.7.1 Company overview
                        7.3.7.2 Financial Performance
                        7.3.7.3 Geographic foothold
                        7.3.7.4 Product benchmarking
                        7.3.7.5 Strategic initiatives

List of Tables

TABLE 1 North America respiratory disease testing market, by product, 2014 - 2025 (USD Million)
TABLE 2 North America respiratory measurement devices market, 2014 - 2025 (USD Million)
TABLE 3 North America respiratory disease testing market, by end-use, 2014 - 2025 (USD Million)
TABLE 4 US respiratory disease testing market, by product, 2014 - 2025 (USD Million)
TABLE 5 US respiratory measurement devices market, 2014 - 2025 (USD Million)
TABLE 6 US respiratory disease testing market, by end-use, 2014 - 2025 (USD Million)
TABLE 7 Canada respiratory disease testing market, by product, 2014 - 2025 (USD Million)
TABLE 8 Canada respiratory measurement devices market, 2014 - 2025 (USD Million)
TABLE 9 Canada respiratory disease testing market, by end-use, 2014 - 2025 (USD Million)
TABLE 10 Europe respiratory disease testing market, by product, 2014 - 2025 (USD Million)
TABLE 11 Europe respiratory measurement devices market, 2014 - 2025 (USD Million)
TABLE 12 Europe respiratory disease testing market, by end-use, 2014 - 2025 (USD Million)
TABLE 13 UK respiratory disease testing market, by product, 2014 - 2025 (USD Million)
TABLE 14 UK respiratory measurement devices market, 2014 - 2025 (USD Million)
TABLE 15 UK respiratory disease testing market, by end-use, 2014 - 2025 (USD Million)
TABLE 16 Germany respiratory disease testing market, by product, 2014 - 2025 (USD Million)
TABLE 17 Germany respiratory measurement devices market, 2014 - 2025 (USD Million)
TABLE 18 Germany respiratory disease testing market, by end-use, 2014 - 2025 (USD Million)
TABLE 19 Asia Pacific respiratory disease testing market, by product, 2014 - 2025 (USD Million)
TABLE 20 Asia Pacific respiratory measurement devices market, 2014 - 2025 (USD Million)
TABLE 21 Asia Pacific respiratory disease testing market, by end-use, 2014 - 2025 (USD Million)
TABLE 22 Japan respiratory disease testing market, by product, 2014 - 2025 (USD Million)
TABLE 23 Japan respiratory measurement devices market, 2014 - 2025 (USD Million)
TABLE 24 Japan respiratory disease testing market, by end-use, 2014 - 2025 (USD Million)
TABLE 25 China respiratory disease testing market, by product, 2014 - 2025 (USD Million)
TABLE 26 China respiratory measurement devices market, 2014 - 2025 (USD Million)
TABLE 27 China respiratory disease testing market, by end-use, 2014 - 2025 (USD Million)
TABLE 28 Latin America respiratory disease testing market, by product, 2014 - 2025 (USD Million)
TABLE 29 Latin America respiratory measurement devices market, 2014 - 2025 (USD Million)
TABLE 30 Latin America respiratory disease testing market, by end-use, 2014 - 2025 (USD Million)
TABLE 31 Brazil respiratory disease testing market, by product, 2014 - 2025 (USD Million)
TABLE 32 Brazil respiratory measurement devices market, 2014 - 2025 (USD Million)
TABLE 33 Brazil respiratory disease testing market, by end-use, 2014 - 2025 (USD Million)
TABLE 34 Mexico respiratory disease testing market, by product, 2014 - 2025 (USD Million)
TABLE 35 Mexico respiratory measurement devices market, 2014 - 2025 (USD Million)
TABLE 36 Mexico respiratory disease testing market, by end-use, 2014 - 2025 (USD Million)
TABLE 37 MEA respiratory disease testing market, by product, 2014 - 2025 (USD Million)
TABLE 38 MEA respiratory measurement devices market, 2014 - 2025 (USD Million)
TABLE 39 MEA respiratory disease testing market, by end-use, 2014 - 2025 (USD Million)
TABLE 40 South Africa respiratory disease testing market, by product, 2014 - 2025 (USD Million)
TABLE 41 South Africa respiratory measurement devices market, 2014 - 2025 (USD Million)
TABLE 42 South Africa respiratory disease testing market, by end-use, 2014 - 2025 (USD Million)